Emerging infectious diseases · 2015 · 67 citations · 11 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceBacteriologyMedical MicrobiologyAntibiotic ResistanceAntimicrobial Resistance ControlAntimicrobial Resistance PreventionBacterial EpidemiologyBacterial InfectionsPathogen DetectionCarbapenem-nonsusceptible IsolatesCarbapenemase EnzymesEnterobacteriaceae DetectionHealth Priority SettingKlebsiella Pneumoniae CarbapenemaseKlebsiella Pneumoniae ResistancePhenotype Definition OperationalizationPhenotype-based Prioritization
Preventing transmission of carbapenemase-producing, carbapenem-resistant Enterobacteriaceae (CP-CRE) is a public health priority. A phenotype-based definition that reliably identifies CP-CRE while minimizing misclassification of non-CP-CRE could help prevention efforts. To assess possible definitions, we evaluated enterobacterial isolates that had been tested and deemed nonsusceptible to >1 carbapenem at US Emerging Infections Program sites. We determined the number of non-CP isolates that met (false positives) and CP isolates that did not meet (false negatives) the Centers for Disease Control and Prevention CRE definition in use during our study: 30% (94/312) of CRE had carbapenemase genes, and 21% (14/67) of Klebsiella pneumoniae carbapenemase-producing Klebsiella isolates had been misclassified as non-CP. A new definition requiring resistance to 1 carbapenem rarely missed CP strains, but 55% of results were false positive; adding the modified Hodge test to the definition decreased false positives to 12%. This definition should be considered for use in carbapenemase-producing CRE surveillance and prevention.
11
Brad Spellberg, R. Guidos, David N. Gilbert et al. · Clinical Infectious Diseases · 2007 · 1.7K citations · Full text
Vital signs: carbapenem-resistant Enterobacteriaceae.
Jesse T. Jacob, Eili Klein, Ramanan Laxminarayan et al. · PubMed Central · 2013 · 509 citations
W. Lledo, M. Hernández, E. Lopez et al. · MMWR Morbidity and Mortality Weekly Report · 2009 · 390 citations
Life Sciences, Infectious Disease Control, Infectious Diseases +17